FIVE PRIME THERAPEUTICS INC Uncategorized Contracts & Agreements

24 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Gross-Up Agreement
FIVE PRIME THERAPEUTICS INC
Biotechnology
2021
Amendment to Offer Letter Agreement by and between the company and William R. Ringo, dated as of April 16, 2020
FIVE PRIME THERAPEUTICS INC
Biotechnology
2020
Offer Letter Agreement by and between the company and Thomas Civik, dated as of April 6, 2020
FIVE PRIME THERAPEUTICS INC
Biotechnology
2020
Letter Agreement by and between the company and William R. Ringo, dated as of March 6, 2020
FIVE PRIME THERAPEUTICS INC
Biotechnology
2020
Letter Agreement by and between the company and Helen Collins, dated as of December 12, 2019
FIVE PRIME THERAPEUTICS INC
Biotechnology
2020
Letter Agreement by and between the company and David V. Smith, dated as of December 12, 2019
FIVE PRIME THERAPEUTICS INC
Biotechnology
2020
Letter Agreement by and between the company and Francis Sarena, dated as of December 12, 2019
FIVE PRIME THERAPEUTICS INC
Biotechnology
2020
Amendment to Offer Letter Agreement by and between the company and William R. Ringo, dated as of December 20, 2019
FIVE PRIME THERAPEUTICS INC
Biotechnology
2020
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
FIVE PRIME THERAPEUTICS INC
Biotechnology
2020
Amendment to Offer Letter Agreement by and between the company and William R. Ringo, dated as of October 8, 2019
FIVE PRIME THERAPEUTICS INC
Biotechnology
2019
Offer Letter Agreement by and between the company and William R. Ringo, dated as of October 4, 2019
FIVE PRIME THERAPEUTICS INC
Biotechnology
2019
Offer Letter Agreement by and between the company and David V. Smith, dated as of October 24, 2018
FIVE PRIME THERAPEUTICS INC
Biotechnology
2019
Offer Letter Agreement by and between the company and Bryan Irving, dated as of July 27, 2017
FIVE PRIME THERAPEUTICS INC
Biotechnology
2019
Offer Letter by and between the company and Helen Collins, dated as of May 12, 2016
FIVE PRIME THERAPEUTICS INC
Biotechnology
2018
Offer Letter Agreement by and between the company and Lewis T. Williams, dated as of November 17, 2017
FIVE PRIME THERAPEUTICS INC
Biotechnology
2018
Offer Letter by and between the Company and Aron Knickerbocker, dated as of October 18, 2017
FIVE PRIME THERAPEUTICS INC
Biotechnology
2017
Five Prime Therapeutics, Inc. • Two Corporate Drive • South San Francisco, CA 94080 • Phone ###-###-#### • Fax ###-###-#### www.fiveprime.com
FIVE PRIME THERAPEUTICS INC
Biotechnology
2017
Five Prime Therapeutics,Inc. · Two Corporate Drive · South San Francisco, CA 94080 · Phone ###-###-#### · Fax ###-###-#### www.fiveprime.com
FIVE PRIME THERAPEUTICS INC
Biotechnology
2014
ANNEX SP SCHEDULE OF PAYMENTS TO NRC
FIVE PRIME THERAPEUTICS INC
Biotechnology
2013
TECHNOLOGY LICENCE AGREEMENT
FIVE PRIME THERAPEUTICS INC
Biotechnology
2013
Page 2 of8
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2013
Indemnity Agreement
FIVE PRIME THERAPEUTICS INC
Biotechnology
DE
2013
Five Prime Therapeutics, Inc. Two Corporate Drive South San Francisco, CA 94080 Main: (415) 365-5600 Fax: (415) 520-9842
FIVE PRIME THERAPEUTICS INC
Biotechnology
2013
Five Prime Therapeutics, Inc. 1650 Owens Street, Suite 200 San Francisco, CA 94158
FIVE PRIME THERAPEUTICS INC
Biotechnology
2013